Moderna to Report First Quarter 2026 Financial Results on Friday, May 1, 2026
Rhea-AI Summary
Moderna (NASDAQ:MRNA) will report first quarter 2026 financial results on Friday, May 1, 2026 with a live conference call and webcast at 8:00 a.m. ET. The company will provide a corporate update during the call.
A live webcast will be available under Events and Presentations in the Investors section of Moderna's website. The archived webcast will appear about two hours after the call and will remain available for one year.
Positive
- None.
Negative
- None.
News Market Reaction – MRNA
In the Apr 15 session, MRNA gained 2.69%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 26 | Earnings date notice | Neutral | -1.5% | Announcement of Q4 2025 earnings call and webcast timing. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings-date scheduling news was followed by a modest -1.48% move, suggesting muted historical reaction to this tag.
Recent news for Moderna includes regulatory and clinical milestones, such as a positive CHMP opinion for mCOMBRIAX and FDA review initiation for mRNA-1010, alongside a major IP settlement with Arbutus/Genevant. Against this backdrop, the current earnings date announcement fits a routine pattern, similar to the Jan 26, 2026 notice for Q4 2025 results that coincided with a -1.48% move, indicating historically limited price impact from such scheduling updates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CAMBRIDGE, MA / ACCESS Newswire / April 15, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, May 1,2026 to report its first quarter 2026 financial results, and provide a corporate update.
A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.
Webcast: https://investors.modernatx.com
The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Moderna Contacts
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire